Epi Profile Section 9 - Public Health Follow-Up Outcomes

Table 11 - Part 1. Public Health Follow-Up Outcomes for Texas TB Cases, 2019

Cases and People Exposed to TB

Case Details Sputum Smear Positive Sputum Smear Negative/Culture Positive Other

Cases Reported in RVCT

504

200

405

- Cases for Investigation

490

193

191

- Cases with No Contacts

14

27

214

Number of Contacts 

7,126

2,458

1,550

Contacts Completely Evaluated 

4,917

1,613

871

Contacts with TB Disease

48

22

21

- Started Treatment

47

22

21

- Completed Treatment

33

20

19

Reasons Why Treatment Not Completed (Contacts with Active TB Disease)

- Death

2

1

1

- Lost to Follow-Up

2

0

0

- Uncooperative

1

0

0

- Unknown

1

0

0

- Missing

8

1

1

Contacts with Latent TB Infection

1,112

289

197

- Treatment Recommended

900

169

132

- Started Treatment

768

130

116

- Completed Treatment

627

109

102

Reasons Why Treatment Not Completed (Contacts with Latent TB Infection)

- Death 

0

0

0

- Moved

0

1

2

- Active TB Developed

0

0

0

- Adverse Effect

5

1

1

- Chose to Stop

11

4

0

- Lost to Follow-up

27

5

1

- Provider Decision

1

0

0

- Uncooperative/Refused Treatment

53

5

3

- Other

8

1

0

- Missing

36

4

7


Table 11 - Part II. Contact Investigation Outcomes for Texas TB cases, 2018

Evaluation Indices

Contact Details Sputum Smear Positive Sputum Smear Negative/Culture Positive Other

No Contacts rate

2.8%

12.3%

52.8%

Contacts per case (n)

14.5

11.7

8.1

Evaluation rate

70.2%

65.6%

56.2%

Disease rate

0.98%

1.4%

2.4%

Treatment rate (contact with disease)

97.9%

100%

100%

Completion rate (contacts with disease)

70.2%

90.9%

90.5%

Latent infection rate

22.6%

18.1%

22.6%

Treatment rate (contacts with latent infection)

85.3%

76.9%

87.9%

Completion rate (contacts with latent infection)

81.6%

83.9%

87.9%


Table of Contents | An Overview of Tuberculosis in Texas | Geographic Distribution of Tuberculosis in Texas | Affected Populations | Case Diagnosis | Recent Transmission | Mortality | Risk Factors Associated with Tuberculosis | Drug Resistant TB | Public Health Follow-Up Outcomes | Reporting Requirements | References